ID - 866
THE EFFICACY OF SUBCUTANEOUS EPCORITAMAB VS STANDARD OF CARE (SCHOLAR-5) IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AFTER ≥2 SYSTEMIC THERAPIES: AN INDIRECT TREATMENT COMPARISON
PA de Moraesa, A Marinatob, A Suredac, S Kambhampatid, K Lintone, V Chirikovf, A Mutebig, A Chhibberg, FR Navarroh, A Wangi, Z Dingf, A Alshreefi, E Favaroh, LdP Danzej, A Danilovd
a Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
b Vida Hematologia, São Paulo, Brazil
c Clinical Hematology Department, Institut Català d’Oncologia – L’Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain
d City of Hope, Duarte, United States
e The Christie NHS Foundation Trust, Manchester Cancer Research Center, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
f OPEN Health, Hingham, United States
g Genmab, United States
j AbbVie, São Paulo, Brazil
Ver más
